Edition:
United Kingdom

Profile: Evofem Biosciences Inc (EVFM.OQ)

EVFM.OQ on NASDAQ Stock Exchange Capital Market

5.41USD
24 May 2019
Change (% chg)

$0.20 (+3.84%)
Prev Close
$5.21
Open
$5.22
Day's High
$5.55
Day's Low
$5.22
Volume
21,497
Avg. Vol
13,825
52-wk High
$7.21
52-wk Low
$1.80

Evofem Biosciences Inc, formerly Neothetics, Inc., incorporated on February 2, 2007, is a clinical-stage specialty biopharmaceutical company. The Company develops products to address unmet needs in women's sexual and reproductive health. The Company’s product Amphora, is a Multipurpose Vaginal pH Regulator (MVP-R) designed to regulate vaginal pH to within the normal range of 3.5 to 4.5 even in the presence of semen.

Amphora maintains an acidic environment which is inhospitable to sperm as well as certain viral and bacterial pathogens associated with sexually transmitted infections. Amphora is used to prevent urogenital chlamydia and gonorrhea in women. The Company is in the second Phase III clinical trial of Amphora for prevention of pregnancy (AMP002). The Company is currently designing a Phase IIb trial for its second product candidate, a MVP-R to reduce the recurrence of bacterial vaginosis.

Company Address

Evofem Biosciences Inc

12400 High Bluff Dr Ste 600
SAN DIEGO   CA   92130-3077
P: +1858.5501900
F: +1858.7501013

Company Web Links